Related Experiment Video

Updated: Jun 11, 2025

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

38.9K

Risankizumab in obese patients with moderate-to-severe plaque psoriasis: a 104-week, real-world, retrospective study

Natalia Rompoti1, Ioannis-Alexios Koumprentziotis2, Irene Stefanaki1

  • 11st Department of Dermatology and Venereology, Medical School, National and Kapodistrian University of Athens, "A. Sygros" Hospital for Skin and Venereal Diseases, I. Dragoumi 5, Athens, 161 21, Greece.

Archives of Dermatological Research
|October 9, 2024
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Interleukin-23ObesityPsoriasisRisankizumab

More Related Videos

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

341
Self-Administration of Drugs in Mouse Models of Feeding and Obesity03:37

Self-Administration of Drugs in Mouse Models of Feeding and Obesity

Published on: June 8, 2021

4.4K

Related Concept Videos